Mechanistically, CeT-loaded HMCLPs increase ROS production, induce mitochondrial damage, and activate caspase-3, leading to tumor cell apoptosis, which provides a promising strategy for future cancer treatment. This evidence concerns the gene CASP3 and cancer.